News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
552,480 Results
Type
Article (33116)
Company Profile (139)
Press Release (519217)
Multimedia
Podcasts (84)
Webinars (15)
Section
Business (151998)
Career Advice (1000)
Deals (27060)
Drug Delivery (99)
Drug Development (53821)
Employer Resources (104)
FDA (12793)
Job Trends (12156)
News (252008)
Policy (25697)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2290)
Academic (2)
Accelerated approval (27)
Adcomms (18)
Allergies (115)
Alliances (37547)
ALS (109)
Alzheimer's disease (1298)
Antibody-drug conjugate (ADC) (209)
Approvals (13108)
Artificial intelligence (430)
Autoimmune disease (111)
Automation (24)
Bankruptcy (241)
Best Places to Work (10279)
BIOSECURE Act (10)
Biosimilars (172)
Biotechnology (82)
Bladder cancer (120)
Brain cancer (43)
Breast cancer (478)
Cancer (3436)
Cardiovascular disease (328)
Career advice (891)
Career pathing (16)
CAR-T (194)
CDC (52)
Cell therapy (533)
Cervical cancer (30)
Clinical research (46648)
Collaboration (1297)
Company closure (1)
Compensation (516)
Complete response letters (34)
COVID-19 (2680)
CRISPR (63)
C-suite (709)
Cystic fibrosis (110)
Data (4785)
Decentralized trials (2)
Denatured (30)
Depression (122)
Diabetes (380)
Diagnostics (5963)
Digital health (51)
Diversity (10)
Diversity, equity & inclusion (30)
Drug discovery (182)
Drug pricing (174)
Drug shortages (14)
Duchenne muscular dystrophy (155)
Earnings (63277)
Editorial (49)
Employer branding (13)
Employer resources (97)
Events (97123)
Executive appointments (856)
FDA (15334)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (21)
Funding (1255)
Gene editing (127)
Generative AI (39)
Gene therapy (378)
GLP-1 (709)
Government (4632)
Grass and pollen (7)
Guidances (345)
Healthcare (17419)
HIV (57)
Huntington's disease (22)
IgA nephropathy (63)
Immunology and inflammation (149)
Immuno-oncology (43)
Indications (93)
Infectious disease (2945)
Inflammatory bowel disease (149)
Inflation Reduction Act (16)
Influenza (116)
Intellectual property (146)
Interviews (125)
IPO (12478)
IRA (43)
Job creations (2293)
Job search strategy (784)
JPM (62)
Kidney cancer (13)
Labor market (47)
Layoffs (309)
Leadership (17)
Legal (5707)
Liver cancer (69)
Longevity (13)
Lung cancer (422)
Lymphoma (270)
Machine learning (28)
Management (38)
Manufacturing (545)
MASH (128)
Medical device (11316)
Medtech (11366)
Mergers & acquisitions (15440)
Metabolic disorders (976)
Multiple sclerosis (127)
NASH (11)
Neurodegenerative disease (216)
Neuropsychiatric disorders (70)
Neuroscience (2230)
Neurotech (1)
NextGen: Class of 2026 (5702)
Non-profit (4230)
Now hiring (18)
Obesity (452)
Opinion (203)
Ovarian cancer (115)
Pain (134)
Pancreatic cancer (158)
Parkinson's disease (196)
Partnered (26)
Patents (285)
Patient recruitment (356)
Peanut (39)
People (47339)
Pharmaceutical (36)
Pharmacy benefit managers (29)
Phase 1 (14698)
Phase 2 (19440)
Phase 3 (15995)
Pipeline (4457)
Policy (258)
Postmarket research (1904)
Preclinical (5258)
Press Release (72)
Prostate cancer (173)
Psychedelics (41)
Radiopharmaceuticals (239)
Rare diseases (652)
Real estate (4172)
Recruiting (44)
Regulatory (18928)
Reports (31)
Research institute (2150)
Resumes & cover letters (115)
Rett syndrome (23)
RNA editing (11)
RSV (71)
Schizophrenia (132)
Series A (192)
Series B (161)
Service/supplier (5)
Sickle cell disease (80)
Special edition (15)
Spinal muscular atrophy (108)
Sponsored (35)
Startups (2768)
State (1)
Stomach cancer (6)
Supply chain (76)
Tariffs (50)
The Weekly (53)
Vaccines (969)
Venture capital (79)
Weight loss (283)
Women's health (87)
Worklife (8)
Date
Today (121)
Last 7 days (456)
Last 30 days (1744)
Last 365 days (23868)
2026 (2994)
2025 (24159)
2024 (28059)
2023 (31832)
2022 (42333)
2021 (46620)
2020 (46027)
2019 (39756)
2018 (29980)
2017 (24073)
2016 (24328)
2015 (28705)
2014 (22347)
2013 (18156)
2012 (19396)
2011 (20100)
2010 (18544)
Location
Africa (664)
Alabama (44)
Alaska (7)
Arizona (218)
Arkansas (13)
Asia (29940)
Australia (4996)
California (8487)
Canada (2949)
China (786)
Colorado (381)
Connecticut (396)
Delaware (243)
Europe (66500)
Florida (1330)
Georgia (288)
Hawaii (2)
Idaho (55)
Illinois (699)
India (64)
Indiana (503)
Iowa (18)
Japan (357)
Kansas (106)
Kentucky (30)
Louisiana (25)
Maine (80)
Maryland (1118)
Massachusetts (6305)
Michigan (242)
Minnesota (534)
Mississippi (3)
Missouri (130)
Montana (23)
Nebraska (22)
Nevada (110)
New Hampshire (72)
New Jersey (2632)
New Mexico (20)
New York (2456)
North Carolina (1218)
North Dakota (6)
Northern California (4256)
Ohio (278)
Oklahoma (18)
Oregon (32)
Pennsylvania (1840)
Puerto Rico (17)
Rhode Island (34)
South America (864)
South Carolina (38)
South Dakota (1)
Southern California (3239)
Tennessee (155)
Texas (1282)
United States (31828)
Utah (320)
Virginia (196)
Washington D.C. (68)
Washington State (770)
West Virginia (3)
Wisconsin (113)
Wyoming (2)
552,480 Results for "emergent health corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP
February 10, 2026
·
7 min read
Press Releases
Optimi Health Announces Equity Incentive Grants and Corporate Update
January 16, 2026
·
4 min read
Press Releases
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
February 12, 2026
·
9 min read
Press Releases
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
·
5 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Legal
Former Emergent CEO Hit With Insider Trading Lawsuit
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with information related to the company’s manufacturing operations that had yet to be made public.
January 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 21, 2026
·
7 min read
Press Releases
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
January 12, 2026
·
5 min read
Press Releases
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
·
1 min read
1 of 55,248
Next
